AstraZeneca’s Nirsevimab: US FDA Wants Input On How It Would Fit With Pediatric RSV Vaccines

 
• By Derrick Gingery
RSV Vaccine
The FDA and CDC could co-develop educational materials for nirsevimab similar to Vaccine Information Statements. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers